Drug
Idebenone clinical trials
- studies test it
- 25
- open now
- 2
- in phase 3
- 11
- first study started
- 2001
Keep track of what changes. Save the idebenone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 10
- Phase 3
- 11
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 12
Santhera Pharmaceuticals (13) · National Institute of Neurological Disorders and Stroke (NINDS) (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2) · Ruijin Hospital (1) · Stanford University (1) · Michio Hirano (1) · Xiangya Hospital of Central South University (1)
Studies
Open first, then newest update. How each study uses idebenone is read from its arms, and is right about nine times in ten.
Testing it · 25
- Idebenone for the Preventive Treatment of MigraineRecruitingPhase 3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04151472Written as 90mg Idebenone
- Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke EpilepsyRecruitingPhase 4Xiangya Hospital of Central South UniversityNCT05987397Written as idebenone 30 mg for 14 days
- Study of Oral Idebenone to Treat Non-Alcoholic SteatohepatitisCompletedPhase 1/2Stanford UniversityNCT04669158Written as Idebenone
- A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into SynucleinopathiesActive, not recruitingPhase 2Ruijin HospitalNCT04534023Written as Idebenone
- A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson DiseaseWithdrawnPhase 2/3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04152655Written as Idebenone
- Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's AtaxiaCompletedPhase 3Santhera PharmaceuticalsNCT00537680Written as Idebenone
- Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia PatientsCompletedPhase 3Santhera PharmaceuticalsNCT00697073Written as Idebenone
- Study to Assess the Efficacy and Safety of Raxone in LHON PatientsCompletedPhase 4Santhera PharmaceuticalsNCT02774005Written as Idebenone
- Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine PatientsStatus unknownPhase 4Beijing Tiantan HospitalNCT05411978Written as Idebenone
- A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid SteroidsTerminatedPhase 3Santhera PharmaceuticalsNCT02814019Written as Idebenone 150 mg film-coated tablets
- Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)TerminatedPhase 3Santhera PharmaceuticalsNCT03603288Written as idebenone 150 mg film-coated tablets
- Idebenone for Primary Progressive Multiple SclerosisCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT01854359Written as Idebenone
- Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)CompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00950248Written as Idebenone
- Idebenone to Treat Friedreich's AtaxiaCompletedPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT00229632Written as Idebenone
- Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)CompletedPhase 3Santhera PharmaceuticalsNCT00993967Written as idebenone
- Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like EpisodesCompletedPhase 2Michio HiranoNCT00887562Written as Idebenone
- A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) PatientsCompletedPhase 3Santhera PharmaceuticalsNCT00905268Written as idebenone
- Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)CompletedPhase 3Santhera PharmaceuticalsNCT01303406Written as Idebenone
- Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)CompletedPhase 3Santhera PharmaceuticalsNCT01027884Written as Idebenone
- Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)WithdrawnPhase 3Santhera PharmaceuticalsNCT01495715Written as Idebenone
See all 25 studies that test idebenone →
Given in every arm · 1 — idebenone is usual care beside what is tested
Codes
What other systems call idebenone · ClinicalTrials.gg INT003066
- MeSH (NLM) C036619idebenoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) HB6PN45W4JIDEBENONEConfirmed FDA, NLM, Wikidata
- RxNorm 51296Confirmed FDA, Wikidata
- Wikidata Q4197874idebenoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74158IdebenoneOne source FDA
- DrugBank DB09081One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C036619 | idebenone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | HB6PN45W4J | IDEBENONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 51296 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4197874 | idebenone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74158 | Idebenone | One source FDA |
| DrugBank | DB09081 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.